Evidence map›Paper›PMID 38045226›Full record

ArticlebioRxiv : the preprint server for biology2024

Hammerhead-type FXR agonists induce an eRNA

Jinjing Chen, Ruoyu Wang, Feng Xiong, Hao Sun, Byron Kemper, Wenbo Li, Jongsook Kim Kemper

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jinjing ChenDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Ruoyu WangDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Feng XiongDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Hao SunDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Byron KemperDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Wenbo LiDepartment of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Jongsook Kim KemperDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.ORCID 0000-0002-5534-0286
University of Illinois Urbana-Champaign · USThe University of Texas Health Science Center at Houston · US

Funding

Regulation of Cholesterol Catabolism by Bile AcidsR01DK062777 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KEMPER, JONGSOOK KIM · 2003 to 2021
$5.8M
Coordination of gut-liver bile acid signaling by FXRR01DK095842 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI KEMPER, JONGSOOK KIM · 2012 to 2021
$3.0M
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome OrganizationR01GM136922 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, WENBO · 2020 to 2024
$2.0M
Condensin-mediated enhancer and chromatin architectural control of breast cancer gene transcriptionK22CA204468 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, WENBO · 2017 to 2019
$486k
Optogenetic Engineering of 3D Chromatin ArchitectureR21GM132778 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, WENBO · 2019 to 2020
$434k
NCI NIH HHS K22 CA204468NIDDK NIH HHS R01 DK062777NIDDK NIH HHS R01 DK095842NIGMS NIH HHS R01 GM136922NIGMS NIH HHS R21 GM132778NLM NIH HHS HHSN276201200017C
6 · The paper itself

Abstract

The nuclear receptor, Farnesoid X Receptor (FXR/NR1H4), is increasingly recognized as a promising drug target for metabolic diseases, including nonalcoholic steatohepatitis (NASH). Protein coding genes regulated by FXR are well known, but whether FXR also acts through regulation of long non-coding RNAs (lncRNAs), which vastly outnumber protein-coding genes, remains unknown. Utilizing RNA-seq and GRO-seq analyses in mouse liver, we found that FXR activation affects the expression of many RNA transcripts from chromatin regions bearing enhancer features. Among these we discovered a previously unannotated liver-enriched enhancer-derived lncRNA (eRNA), termed

Indexed as

enhancerenhancer RNAFXRGro-seqhepatic inflammationlncRNANAFLDNASHnuclear receptorRNA-seqtropifexor

Identifiers

PMID38045226
PMCPMC10690184
OpenAlexW4388868717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.